Bridge Biotherapeutics, Inc. is engaged in the manufacturing of pharmaceutical products. It also engages in the provision pharmacy research, development and experiment of medicines. The company was founded by Jeong-Gyu, Lee on September 17, 2015 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company